首页> 外文期刊>Current topics in medicinal chemistry >Bacterial infection probes and imaging strategies in clinical nuclear medicine and preclinical molecular imaging.
【24h】

Bacterial infection probes and imaging strategies in clinical nuclear medicine and preclinical molecular imaging.

机译:临床核医学和临床前分子成像中的细菌感染探针和成像策略。

获取原文
获取原文并翻译 | 示例
           

摘要

At present, a limited number of strategies exist for diagnostic imaging of patients with bacterial infection. While radiolabeled probes and white blood cells provide robust solutions to detect bacteria in humans, they also give false positives in cases of sterile inflammation. With the onset of bacterial drug resistance, and a clinical trend toward reducing the prescription of antibiotics, the need for highly specific infection detection protocols has been renewed. The preclinical research community has recently utilized new optical imaging strategies, alongside traditional radioimaging research, to develop novel infection probes with translational potential. Here we review the current clinical methods for imaging bacteria in humans, and discuss the efforts within the preclinical community to validate new strategies. The review of preclinical infection imaging probes is limited to those probes that could be feasibly adapted for use in humans with currently available clinical modalities.
机译:当前,存在有限数量的用于细菌感染患者的诊断成像的策略。尽管放射性标记的探针和白细胞为检测人类细菌提供了可靠的解决方案,但在无菌炎症的情况下,它们也会产生假阳性。随着细菌耐药性的出现以及减少抗生素处方的临床趋势,对高特异性感染检测方案的需求已经更新。临床前研究团体最近已利用新的光学成像策略以及传统的放射成像研究来开发具有翻译潜力的新型感染探针。在这里,我们回顾了对人类细菌成像的当前临床方法,并讨论了临床前社区为验证新策略所做的努力。临床前感染成像探针的综述仅限于那些可以适当地适用于具有当前临床模式的人类的探针。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号